As of 2025-07-07, the Relative Valuation of Dyne Therapeutics Inc (DYN) is (66.70) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.76 USD, the upside of Dyne Therapeutics Inc based on Relative Valuation is -861.4%.
The range of the Relative Valuation is (44.25) - (87.20) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.1x - 27.0x | 20.0x |
| Forward P/E multiples | 13.7x - 28.8x | 21.2x |
| Fair Price | (44.25) - (87.20) | (66.70) |
| Upside | -605.1% - -1095.5% | -861.4% |
| Date | P/E |
| 2025-07-03 | -2.71 |
| 2025-07-02 | -2.77 |
| 2025-07-01 | -2.69 |
| 2025-06-30 | -2.95 |
| 2025-06-27 | -2.96 |
| 2025-06-26 | -3.11 |
| 2025-06-25 | -3.23 |
| 2025-06-24 | -3.29 |
| 2025-06-23 | -3.15 |
| 2025-06-20 | -3.20 |
| 2025-06-18 | -3.34 |
| 2025-06-17 | -3.36 |
| 2025-06-16 | -4.28 |
| 2025-06-13 | -4.46 |
| 2025-06-12 | -4.48 |
| 2025-06-11 | -4.51 |
| 2025-06-10 | -4.58 |
| 2025-06-09 | -4.46 |
| 2025-06-06 | -4.55 |
| 2025-06-05 | -4.33 |
| 2025-06-04 | -4.15 |
| 2025-06-03 | -4.11 |
| 2025-06-02 | -3.93 |
| 2025-05-30 | -3.70 |
| 2025-05-29 | -3.79 |
| 2025-05-28 | -3.64 |
| 2025-05-27 | -3.62 |
| 2025-05-23 | -3.62 |
| 2025-05-22 | -3.68 |
| 2025-05-21 | -3.64 |
| 2025-05-20 | -3.82 |
| 2025-05-19 | -3.61 |
| 2025-05-16 | -3.66 |
| 2025-05-15 | -3.63 |
| 2025-05-14 | -3.62 |
| 2025-05-13 | -3.75 |
| 2025-05-12 | -3.89 |
| 2025-05-09 | -3.53 |
| 2025-05-08 | -3.50 |
| 2025-05-07 | -2.91 |
| 2025-05-06 | -3.10 |
| 2025-05-05 | -3.66 |
| 2025-05-02 | -3.67 |
| 2025-05-01 | -3.71 |
| 2025-04-30 | -3.65 |
| 2025-04-29 | -3.63 |
| 2025-04-28 | -3.49 |
| 2025-04-25 | -3.42 |
| 2025-04-24 | -3.44 |
| 2025-04-23 | -3.34 |